Health-related quality of life in patients with progressive midgut neuroendocrine tumors treated With 177Lu-Dotatate in the phase III NETTER-1 trial - Strosberg, J; Wolin, E; Chasen, B (J Clin Oncol, 2018)
, et al; NETTER-1 Study Group.